Thus, to test the prognostic value of maspin mRNA expression in breast cancer, we chose to analyse a well-defined cohort of 105 postmenopausal patients with ERα-positive breast cancer treated with primary surgery followed by adjuvant tamoxifen alone. The gene discussed is ESR1; the disease is breast carcinoma.